English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1564876      線上人數 : 427
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於CMUR管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/29600


    題名: Discordance between dipyridamole stress technetium-99m tetrofosmin single photon emission computed tomography and coronary angiography in patients with Kawasaki disease
    作者: Fu, YC;Shiau, YC;Tsai, SC;Kao, A;Hwang, BT;Chi, CS
    貢獻者: 附設醫院核子醫學部;China Med Coll Hosp, Dept Nucl Med, Taichung 404, Taiwan;China Med Coll Hosp, Dept Med Res, Taichung 404, Taiwan;Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan;Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan;Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan;Natl Taiwan Univ, Dept Nucl Med, Far Eastern Mem Hosp, Coll Elect Engn, Taipei 10764, Taiwan;Natl Taiwan Univ, Inst Biomed Engn, Coll Elect Engn, Taipei 10764, Taiwan;Show Chwan Mem Hosp, Dept Nucl Med, Changhua, Taiwan
    日期: 2002
    上傳時間: 2010-09-24 14:38:38 (UTC+8)
    出版者: KLUWER ACADEMIC PUBL
    摘要: The purpose of this study was investigate the role of 18F-2deoxyglucose positron emission tomography (FDG-PET) in staging small cell lung cancer (SCLC), its efficacy for the discrimination of limited disease (LD) and extensive disease (ED) stages and its regional sensitivity for different metastatic locations. Twenty-five patients with histologically confirmed SCLC and 42 radiologically-staged tumor sites were retrospectively investigated. The LD sample included 10 patients while the ED included 15 patients. All of the 25 primary tumor sites (100%) were visualized and 41 out of 42 (97.6%) of the metastases could be identified, but FDG-PET was needed for anatomical localization. The efficacy of FDG-PET was studied in the staging of SCLC patients and compared with the initial staging of conventional modality findings. FDG-PET down-staged (from ED to LD) one case and up-staged (from LD to ED) one case of SCLC. In summary, all of the patients with ED were correctly staged by FDG-PET alone. We conclude that FDG-PET is a substantial tool in the staging work-up of SCLC if it is performed initially to allow fast identification of patients with extensive disease stages and thus saves additional radiological or invasive examinations. Our preliminary results support the usefulness of whole body FDG-PET for staging SCLC.
    關聯: INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING 18(5):357-362
    顯示於類別:[台中附設醫院] 期刊論文

    文件中的檔案:

    沒有與此文件相關的檔案.



    在CMUR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋